Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Clinical Test Volume: 53,100 tests, a 21% increase year-over-year. Biopharma Revenue: $39.4 million, a 34% increase year-over-year. Guardant360 ASP: Achieved $3,000, ahead of the 2028 target. Non-GAAP Gross Margin: 65% in Q3 2024. Adjusted EBITDA Loss: $56.2 million, improved by $23.5 million from Q3 2023. Free Cash Flow: Negative $55.3 million, an improvement of $24.9 million from Q3 2023. Cash Position: Approximately $1 billion at the end of Q3 2024. Full Year 2024 Revenue Guidance: Increased to $720 million to $725 million, representing 28% to 29% growth. Warning! GuruFocus has detected 5 Warning Signs with GH. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Guardant Health Inc ( NASDAQ:GH ) reported a 34% increase in total revenue, reaching a record $191.5 million for Q3 2024. The company launched Shield, its first test for the asymptomatic cancer screening market, which ha
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market [Yahoo! Finance]Yahoo! Finance
- Rafay Recognized on the 2024 Deloitte Technology Fast 500™ [Yahoo! Finance]Yahoo! Finance
- OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI [TechCrunch]TechCrunch
- Plug and Play partners with Daimler Truck North America and Daimler Truck Financial Services to Enhance the Supply Chain Industry [Yahoo! Finance]Yahoo! Finance
- Plug and Play announces expansion into Seattle along with Partnership with SBI Holdings and SNBL and Future Participation as co-GP in SBI US Gateway Fund [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 11/6/24 - Beat
GH
Sec Filings
- 11/19/24 - Form 4
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- GH's page on the SEC website